Pomanda estimates the enterprise value of EUROMED PHARMA UK LTD at £2.7m based on a Turnover of £5.3m and 0.5x industry multiple (adjusted for size and gross margin).
euromed pharma uk ltdEstimated Valuation
£2.4m
Pomanda estimates the enterprise value of EUROMED PHARMA UK LTD at £2.4m based on an EBITDA of £522.5k and a 4.6x industry multiple (adjusted for size and gross margin).
euromed pharma uk ltdEstimated Valuation
£2.2m
Pomanda estimates the enterprise value of EUROMED PHARMA UK LTD at £2.2m based on Net Assets of £1.2m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Euromed Pharma Uk LtdOverview
Euromed Pharma Uk Ltd is a live company located in hampshire, GU14 8FF with a Companies House number of 08992811. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 2014, it's largest shareholder is
fin posillipo s.p.a.
with a 100% stake. Euromed Pharma Uk Ltd is a established,
mid sized company, Pomanda has estimated its turnover at
£5.3m with
declining
growth in recent years.
Pomanda's financial health check has awarded Euromed Pharma Uk Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
6 Strong
2 Regular
4 Weak
Size
annual sales of £9.3m, make it smaller than the average company (£24.7m)
£9.3m - Euromed Pharma Uk Ltd
£24.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.1%)
3% - Euromed Pharma Uk Ltd
5.1% - Industry AVG
Production
with a gross margin of 13.8%, this company has a higher cost of product (26.8%)
13.8% - Euromed Pharma Uk Ltd
26.8% - Industry AVG
Profitability
an operating margin of 6.2% make it more profitable than the average company (3.9%)
6.2% - Euromed Pharma Uk Ltd
3.9% - Industry AVG
Employees
with 12 employees, this is below the industry average (36)
12 - Euromed Pharma Uk Ltd
36 - Industry AVG
Pay Structure
on an average salary of £76.3k, the company has an equivalent pay structure (£76.3k)
£76.3k - Euromed Pharma Uk Ltd
£76.3k - Industry AVG
Efficiency
resulting in sales per employee of £774.9k, this is more efficient (£671k)
£774.9k - Euromed Pharma Uk Ltd
£671k - Industry AVG
Debtor Days
it gets paid by customers after 29 days, this is earlier than average (58 days)
29 days - Euromed Pharma Uk Ltd
58 days - Industry AVG
Creditor Days
its suppliers are paid after 35 days, this is close to average (33 days)
35 days - Euromed Pharma Uk Ltd
33 days - Industry AVG
Stock Days
it holds stock equivalent to 15 days, this is less than average (55 days)
15 days - Euromed Pharma Uk Ltd
55 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 38 weeks, this is more cash available to meet short term requirements (10 weeks)
38 weeks - Euromed Pharma Uk Ltd
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 47.7%, this is a lower level of debt than the average (58.6%)
47.7% - Euromed Pharma Uk Ltd
58.6% - Industry AVG
EUROMED PHARMA UK LTD financials
EXPORT
Euromed Pharma Uk Ltd's latest turnover from December 2023 is estimated at £5.3 million and the company has net assets of £1.2 million. According to their latest financial statements, Euromed Pharma Uk Ltd has 12 employees and maintains cash reserves of £891.9 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Turnover
5,349,375
9,298,612
7,054,463
7,244,952
8,633,328
9,844,891
7,990,087
1,391,819
906,031
444,772
Other Income Or Grants
Cost Of Sales
3,769,356
8,012,485
5,948,959
6,397,383
7,738,069
9,000,479
7,399,645
1,023,994
666,429
323,041
Gross Profit
1,580,019
1,286,127
1,105,504
847,569
895,259
844,412
590,442
367,826
239,602
121,731
Admin Expenses
1,059,993
711,349
644,691
771,417
656,803
490,299
303,612
177,442
239,750
115,896
Operating Profit
520,026
574,778
460,813
76,152
238,456
354,113
286,830
190,384
-148
5,835
Interest Payable
3,363
Interest Receivable
36,422
1,519
1,484
2,623
1,676
610
248
175
209
21
Pre-Tax Profit
556,448
576,297
462,297
78,775
240,132
354,723
283,715
190,559
61
5,856
Tax
-139,112
-120,422
-90,194
-27,455
-46,215
-67,334
-54,153
-36,206
-12
-1,171
Profit After Tax
417,336
455,875
372,103
51,320
193,917
287,389
229,562
154,353
49
4,685
Dividends Paid
182,651
170,000
105,000
100,000
98,000
Retained Profit
417,336
273,224
202,103
-53,680
93,917
189,389
229,562
154,353
49
4,685
Employee Costs
983,220
915,457
759,587
790,139
656,652
615,430
487,687
328,195
220,984
42,382
Number Of Employees
12
12
11
12
11
10
8
6
5
1
EBITDA*
522,486
578,343
464,489
81,938
244,429
357,737
290,593
191,663
372
6,004
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Tangible Assets
13,438
13,757
11,686
15,362
19,678
13,071
11,269
3,833
1,390
508
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
13,438
13,757
11,686
15,362
19,678
13,071
11,269
3,833
1,390
508
Stock & work in progress
358,768
347,343
178,711
276,962
191,107
177,686
84,594
88,337
61,869
23,360
Trade Debtors
804,030
739,761
681,924
558,882
856,082
682,299
416,749
147,993
76,249
62,806
Group Debtors
6,291
73,911
77,668
5,190
Misc Debtors
174,079
159,365
85,822
223,442
225,950
141,692
114,652
134,101
20,745
Cash
891,908
677,396
495,603
531,183
285,570
243,279
338,628
65,255
75,087
8,594
misc current assets
total current assets
2,228,785
1,930,156
1,442,060
1,664,380
1,636,377
1,250,146
954,623
435,686
233,950
94,760
total assets
2,242,223
1,943,913
1,453,746
1,679,742
1,656,055
1,263,217
965,892
439,519
235,340
95,268
Bank overdraft
Bank loan
29,167
Trade Creditors
852,932
785,079
574,309
840,196
975,398
680,659
509,118
196,017
45,542
90,483
Group/Directors Accounts
29,309
26,643
other short term finances
hp & lease commitments
other current liabilities
225,599
139,114
104,701
45,599
82,273
79,319
142,704
56,944
184,686
total current liabilities
1,078,531
924,193
708,319
914,962
1,057,671
759,978
651,822
279,604
230,228
90,483
loans
220,833
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
2,698
2,838
1,769
2,392
3,149
1,921
2,141
728
278
total long term liabilities
2,698
2,838
1,769
223,225
3,149
1,921
2,141
728
278
total liabilities
1,081,229
927,031
710,088
1,138,187
1,060,820
761,899
653,963
280,332
230,506
90,483
net assets
1,160,994
1,016,882
743,658
541,555
595,235
501,318
311,929
159,187
4,834
4,785
total shareholders funds
1,160,994
1,016,882
743,658
541,555
595,235
501,318
311,929
159,187
4,834
4,785
Dec 2023
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Operating Activities
Operating Profit
520,026
574,778
460,813
76,152
238,456
354,113
286,830
190,384
-148
5,835
Depreciation
2,460
3,565
3,676
5,786
5,973
3,624
3,763
1,279
520
169
Amortisation
Tax
-139,112
-120,422
-90,194
-27,455
-46,215
-67,334
-54,153
-36,206
-12
-1,171
Stock
180,057
168,632
-98,251
85,855
13,421
93,092
-3,743
26,468
38,509
23,360
Debtors
210,363
137,671
-88,489
-303,465
330,519
297,780
249,307
185,100
34,188
62,806
Creditors
278,623
210,770
-265,887
-135,202
294,739
171,541
313,101
150,475
-44,941
90,483
Accruals and Deferred Income
120,898
34,413
59,102
-36,674
2,954
-63,385
85,760
-127,742
184,686
Deferred Taxes & Provisions
929
1,069
-623
-757
1,228
-220
1,413
450
278
Cash flow from operations
393,404
397,870
353,627
99,460
153,195
7,467
391,150
-32,928
67,686
9,150
Investing Activities
capital expenditure
-4,212
-5,636
-1,470
-12,580
-5,426
-11,199
-3,722
-1,402
-677
Change in Investments
cash flow from investments
-4,212
-5,636
-1,470
-12,580
-5,426
-11,199
-3,722
-1,402
-677
Financing Activities
Bank loans
-29,167
29,167
Group/Directors Accounts
-29,309
-29,309
29,309
-26,643
26,643
Other Short Term Loans
Long term loans
-220,833
220,833
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-76,820
100
interest
36,422
1,519
1,484
2,623
1,676
610
-3,115
175
209
21
cash flow from financing
7,113
-27,790
-219,207
252,623
1,676
610
-106,578
26,818
209
121
cash and cash equivalents
cash
396,305
181,793
-35,580
245,613
42,291
-95,349
273,373
-9,832
66,493
8,594
overdraft
change in cash
396,305
181,793
-35,580
245,613
42,291
-95,349
273,373
-9,832
66,493
8,594
euromed pharma uk ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for euromed pharma uk ltd. Get real-time insights into euromed pharma uk ltd's credit score, group structure and payment trends.
Perform a competitor analysis for euromed pharma uk ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in GU14 area or any other competitors across 12 key performance metrics.
euromed pharma uk ltd Ownership
EUROMED PHARMA UK LTD group structure
Euromed Pharma Uk Ltd has no subsidiary companies.
Ultimate parent company
FIN POSILLIPO SPA
#0093972
1 parent
EUROMED PHARMA UK LTD
08992811
EUROMED PHARMA UK LTD Shareholders
The sole shareholder of Euromed Pharma Uk Ltd is Fin Posillipo S.P.A..
fin posillipo s.p.a.
100%
euromed pharma uk ltd directors
Euromed Pharma Uk Ltd currently has 3 directors.
The longest serving directors include
Mr Raffaele Petrone (Sep 2023) and
Ms Susan Matthews (Jul 2024).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to euromed pharma uk ltd.
euromed pharma uk ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EUROMED PHARMA UK LTD. This can take several minutes, an email will notify you when this has completed.
euromed pharma uk ltdCompanies House Filings - See Documents
